Review
Published on 13 Oct 2025
The role of cytostatic in oxidative stress reactions
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1667522
- 485 views
Type at least 3 characters
1,102 articles
Case Report
Published on 13 Oct 2025
A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1658621
- 222 views
Editorial
Published on 10 Oct 2025
Editorial: Drug development for pancreatic cancer: novel targets, drug candidates and mechanisms
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1705678
- 568 views
Original Research
Published on 08 Oct 2025
Lathyrol inhibits the proliferation of Renca cells by altering expression of TGF-β/Smad pathway components and subsequently affecting the cell cycle
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1629962
- 532 views
Case Report
Published on 06 Oct 2025
Case Report: Bevacizumab-induced renal-limited TMA and FSGS-like lesions in a kidney transplant recipient
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1638274
- 554 views
Correction
Published on 01 Oct 2025
Correction: Chorordin-like 1 inhibits pancreatic cancer cell migration and invasion: involvement of the BMP4/SMAD pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1705973
- 866 views
Systematic Review
Accepted on 30 Sep 2025
Evaluating the efficacy and safety of tebentafusp in the treatment of metastatic uveal melanoma: A 2025 update systematic review and meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1667282
Correction
Published on 29 Sep 2025
Correction: Integrating network pharmacology and transcriptomics to identify solasonine’s anti-osteosarcoma targets and experimental validation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1682157
- 615 views
Review
Accepted on 26 Sep 2025
Overcoming Cancer Drug Resistance: Insights into Apoptotic Pathway Modulation by Plant based Nanoparticle and Natural Products
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1677380
- 457 views
Original Research
Published on 26 Sep 2025
Andrographolide suppresses chondrosarcoma cell migration and invasion by inhibiting the PI3K/Akt/mTOR signaling pathway and activating autophagy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1622666
- 1,836 views
Data Report
Published on 25 Sep 2025
An analysis of FDA drug approvals for oncological hematological malignancies in relation to companion diagnostics
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1635491
- 2,266 views
Editorial
Published on 24 Sep 2025
Editorial: Head and neck squamous cell carcinoma: navigating the dawn of personalized medicine
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1684617
- 1,208 views
Editorial
Published on 24 Sep 2025
Editorial: Immune checkpoints regulatory mechanisms and immunotherapy strategies in gastrointestinal tumors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1697974
- 1,407 views
Review
Published on 17 Sep 2025
Recombinant human adenovirus type 5 administration for the treatment of malignant ascites or pleural effusion in cancer patients: a meta-analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1592995
- 1,022 views
Original Research
Published on 05 Sep 2025
Osthole suppresses prostate cancer progression by modulating PRLR and the JAK2/STAT3 signaling axis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1630181
- 1,051 views
Original Research
Published on 03 Sep 2025
Oleanolic acid alleviates ovarian cancer by regulating the miR-122/PDK4 axis to induce autophagy and inhibit glycolysis in vivo and in vitro
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2025.1670758
- 1,274 views